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A B S T R A C T
The link between neurotransmitter-level eﬀects of antidepressants and their clinical eﬀect remain poorly
understood. A single dose of mirtazapine decreases limbic responses to fearful faces in healthy subjects, but it is
unknown whether this eﬀect applies to complex emotional situations and dynamic connectivity between brain
regions. Thirty healthy volunteers listened to spoken emotional narratives during functional magnetic resonance
imaging (fMRI). In an open-label design, 15 subjects received 15 mg of mirtazapine two hours prior to fMRI
while 15 subjects served as a control group. We assessed the eﬀects of mirtazapine on regional neural responses
and dynamic functional connectivity associated with valence and arousal. Mirtazapine attenuated responses to
unpleasant events in the right fronto-insular cortex, while modulating responses to arousing events in the core
limbic regions and the cortical midline structures (CMS). Mirtazapine decreased responses to unpleasant and
arousing events in sensorimotor areas and the anterior CMS implicated in self-referential processing and
formation of subjective feelings. Mirtazapine increased functional connectivity associated with positive valence
in the CMS and limbic regions. Mirtazapine triggers large-scale changes in regional responses and functional
connectivity during naturalistic, emotional stimuli. These span limbic, sensorimotor, and midline brain
structures, and may be relevant to the clinical eﬀectiveness of mirtazapine.
1. Introduction
To develop more speciﬁc and eﬃcient interventions for depression,
understanding the brain network level mechanisms of action of
available, eﬀective medications would be valuable. Since the pathogen-
esis of depression is understood as dysfunctions of large-scale brain
circuitries involved in emotional and cognitive processes (Kaiser et al.,
2015), using complex and naturalistic stimuli and taking into account
not only regional, but also network-level eﬀects, could provide new
insights about the eﬀects of antidepressants on these circuitries.
Antidepressants have been shown to inﬂuence resting state functional
connectivity (Li et al., 2013), but their eﬀect on large-scale functional
connectivity during emotional processing remains unresolved. Antide-
pressants inﬂuence emotional processing, e.g. decreasing limbic re-
sponses to negative stimuli, as early as a few hours or days after
administration (Harmer and Cowen, 2013). Previous studies have
quantiﬁed the eﬀect of antidepressants on brain responses to brieﬂy
ﬂashed emotional stimuli, most commonly emotional facial expressions
(e.g. (Harmer et al., 2006; Norbury et al., 2007), see Ma (2015) for
meta-analysis). Although facial expressions are important in social
interaction and interpreting the emotions of others, they provide a
simpliﬁed model for emotional responses, lacking information about
the dynamic nature of real-life information processing.
Storytelling is a fundamental means of natural human social
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interaction occurring in the forms of face-to-face communication, TV,
radio, and movies. It is also a powerful way of eliciting strong
emotional sensations; interpreting the emotions of others and sharing
one's emotions via spoken and written narratives are crucial for social
interaction. Therefore, auditory narratives provide a powerful model
for daily emotional responses. Emotional stories activate the brain's
emotional circuits similarly to simple visual emotional stimuli (Ferstl
et al., 2005; Wallentin et al., 2011), consequently triggering changes in
sensorimotor and visceral systems (Vrana and Lang, 1990), enabling
humans to extract the emotional content from spoken or written stories.
Recently, the networks of brain areas related to sound processing,
language comprehension, and emotional and self-referential processing
have been shown to become synchronized across healthy persons
listening to emotional, spoken narratives (Nummenmaa et al.,
2014b). Moreover, similarity in brain activity between subjects is
associated with similarity in experienced emotional state
(Nummenmaa et al., 2014b). Importantly, spoken narratives elicit
strong, time-variable emotional reactions, the time series of which
can be accurately tracked. They can thus be used for modeling the
eﬀects of emotion states on large-scale, dynamic connectivity changes.
Several monoaminergic antidepressants rapidly improve recogni-
tion of happy facial expressions in healthy volunteers (Harmer et al.,
2003a, 2008, 2003b; Murphy et al., 2009) (but see also Browning et al.
(2007), Harmer et al. (2004) for negative results). At the neural level,
antidepressants decrease amygdala responses to negative stimuli
(Anderson et al., 2007; Del-Ben et al., 2005; Murphy et al., 2009;
Takahashi et al., 2005), even though increased responses (Bigos et al.,
2008) and null eﬀects (Norbury et al., 2009) have been also reported.
Antidepressant eﬀects elsewhere in the brain are less consistent, but
decreased responses to negative stimuli in healthy volunteers have been
reported in the ventrolateral prefrontal cortex (VLPFC) (Del-Ben et al.,
2005; Takahashi et al., 2005), medial prefrontal cortex (MPFC) (Grady
et al., 2013; Harmer et al., 2006), and striatum (Grady et al., 2013;
Takahashi et al., 2005). These early changes counteract the negative
information processing bias in depressed patients, a core factor in the
pathogenesis of depression (Disner et al., 2011; Gotlib and Joormann,
2010), and may be essential for the sustained therapeutic eﬀect of
antidepressants. Indeed, improved recognition of positive social cues
after a one-week administration of the antidepressants citalopram or
reboxetine predicts future treatment response (Shiroma et al., 2014;
Tranter et al., 2009).
Mirtazapine is a commonly used serotonergic and noradrenergic
antidepressant (Fawcett and Barkin, 1998) that decreases recognition of
fearful faces (Arnone et al., 2009), without the initial increase typical of
the selective serotonin reuptake inhibitor citalopram (Harmer and
Cowen, 2013). A single dose of mirtazapine also enhances memory
for positive emotional events (Arnone et al., 2009). At the neural level,
mirtazapine decreases right amygdala-hippocampal and frontostriatal
responses to fearful versus happy facial expressions, increases responses
of the parietal cortex to a reward task, and attenuates responses of the
cortical midline structures (CMS) during self-referential processing after
a single dose (Komulainen et al., 2016; Rawlings et al., 2010; Vollm
et al., 2006). Thus, mirtazapine may rapidly decrease processing of
threatening stimuli and increase processing of positive or rewarding
stimuli and inﬂuence self-related processing.
Here we used spoken emotional narratives to investigate antide-
pressant eﬀects on brain responses in healthy volunteers. We assessed
whether/how a single dose of mirtazapine inﬂuences neural responses
to continuously recorded valence and arousal dimensions of spoken
emotional narratives. Further, we assessed how mirtazapine inﬂuences
dynamic functional connectivity associated with valence and arousal
using seed-based phase synchronization (SBPS), a novel method,
allowing us to assess dynamic functional connectivity between every
voxel of the brain. We aimed to investigate the early eﬀects of
mirtazapine on instantaneously varying functional connectivity related
to dynamic emotional stimuli, modeling complex and dynamic daily life
emotional situations. We expected mirtazapine to decrease neural
responses to negative events (negative valence) of the narratives in
the emotional circuits of the brain.
2. Methods
2.1. Subjects
The participants were 30 healthy, native Finnish-speaking, right-
handed volunteers aged 18–35 years. They were recruited via adver-
tisement for university students and word of mouth. The participants
were screened with the Structured Clinical Interview for DSM-IV Axis I
Disorders (First et al., 2002) by an investigator (either psychiatrist or
psychiatric resident) of the research group. Exclusion criteria included
any current or life-time psychiatric disorder, current use of illicit drugs
or excessive consumption of alcohol (> 24 U/week for men and>16
U/week for women), and use of antidepressants, antipsychotic agents,
mood stabilizers, systemic corticosteroids, beta blockers, or benzodia-
zepines. The study was approved by the Ethics Committee of Helsinki
and Uusimaa Hospital District and conducted in accordance with the
Declaration of Helsinki. Written informed consent was obtained from
each participant.
The participants were allocated into two groups to either receive a
single dose of mirtazapine 15 mg two hours prior to the fMRI or be
scanned without mirtazapine as a control group in an open-label design.
The study was originally designed as randomized, placebo-controlled
and double-blind, but in contrast to earlier reports (Rawlings et al.,
2010; Vollm et al., 2006), scanning of the ﬁrst ten subjects revealed that
plausible double-blinding was not possible due to sedative eﬀects of
mirtazapine. Consequently, the blinding was broken for both researcher
and subject and the study was re-designed as an open-label protocol.
During the open-label phase we excluded six participants from the
mirtazapine group due to excessive sedation or sleeping during the
fMRI (participant reported that she/he had fallen asleep during the task
or was asleep after the task or response rate in the task was<90%).
Data collection was continued until there were 15 subjects without
excessive sedation in both groups (6 male, 24 female, mean age 24
years, SD 3.72). Thus, the ﬁnal sample comprised 30 participants. There
were no signiﬁcant diﬀerences in age, comprehensive school grade
point average (p=0.926 and p=0.893, respectively, in independent
samples t-test) or gender (p=0.128 in Fisher's exact test) between the
excluded and included subjects.
As an estimate of the sedative eﬀect of mirtazapine, a self-assess-
ment of tiredness (on a likert scale from 1 to 5) was performed at
baseline (assessment time 1, 2 h before the fMRI) and right before the
fMRI (assessment time 2).
2.2. Task and stimuli
The task and stimuli are described in Fig. 1. During fMRI the
participants listened to thirty 45-s spoken narratives describing un-
pleasant, neutral, and pleasant events, with ten stories for each category
(Nummenmaa et al., 2014b). The recorded narratives were read by a
neutral female voice that provided no prosodic cues for the aﬀective
signiﬁcance of the story content. The time series of valence and arousal
dimensions of the narratives were derived from a previous study
(Nummenmaa et al., 2014b), where 18 healthy volunteers (12 females,
age 19–30 years, mean age 24.4 years) listened to the narratives and
rated their emotional feelings (Table 1). The ratings averaged across
subjects formed the time-series that were used as predictors in the fMRI
analyses. The narratives evoked strong emotional reactions and acti-
vated emotional circuits of the brain (Nummenmaa et al., 2014b).
Subjects were instructed to listen to the narratives as if they were
listening to the radio or a podcast and to try to become immersed in the
stories by imagining the described events vividly. Each narrative was
preceded by a 5 s ﬁxation cross and a 15 s text explaining the general
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setting of the forthcoming narrative without revealing its actual
content. The latter epoch also served as a washout period for the
emotion elicited by the previous narrative. During fMRI the stimuli
were delivered using Presentation software (Neurobehavioral Systems
Inc., Albany, CA, USA). The narratives were played to the subjects with
an UNIDES ADU2a audio system (Unides Design, Helsinki, Finland) via
plastic tubes through porous EAR-tip (Etymotic Research, ER3, IL, USA)
earplugs. Sound was adjusted for each subject to be loud enough to be
heard over the scanner noise.
2.3. fMRI acquisition and statistical analysis
Statistical analyses of baseline characteristics (age and comprehen-
sive school grade point average) and the self-assessment of tiredness
were performed with SPSS Statistics software, version 21 (IBM
Corporation, Armonk, NY, USA). Independent samples t-test was used
for baseline characteristics and repeated-measures analysis of variance
(ANOVA) with group and assessment time as factors for the self-
assessment of tiredness.
The MR imaging was performed on a 3T MAGNETOM Skyra whole-
body scanner (Siemens Healthcare, Erlangen, Germany) at the
Advanced Magnetic Imaging Center, Aalto NeuroImaging, Aalto
University School of Science. Image acquisition has been described in
detail previously (Nummenmaa et al., 2014b). Preprocessing and
analysis were performed with SPM8 software (http://www.ﬁl.ion.ucl.
ac.uk/spm/). EPI images were realigned to the ﬁrst scan by rigid-body
transformation to correct head movements, co-registered and normal-
ized to standard template (Montreal Neuroimaging Institute template)
with linear and non-linear transformations and smoothed with Gaussian
kernel of FWHM 8 mm.
A random-eﬀects model was implemented using a two-stage pro-
cess. The ﬁrst level (within-subject) general linear model (GLM)
modeled the eﬀect of valence and arousal parameters on BOLD
response. The model included two explanatory variables, valence and
arousal time series, and realignment parameters as eﬀects of no interest
to account for motion related variance. A high-pass ﬁlter of 128 s and
AR(1) modeling of temporal autocorrelation were applied. Individual
contrast images were generated for positive and negative eﬀects of
valence and arousal. In the second level models the resulting ﬁrst-level
contrast images were subjected to random eﬀects analysis.
We ﬁrst modeled the brain responses to the valence and arousal
dimensions in the control group to track the neural correlates of valence
and arousal without drug-eﬀect by one-sample t-test. Next, the drug-
speciﬁc eﬀects were assessed by comparing the drug group and the
control group by independent samples t-test. To quantify diﬀerences in
sensory processing, the stories were modeled as boxcar functions and
resulting contrast images were compared between the groups. The
Statistical threshold was set at p<0.05, FDR corrected at cluster level.
We then assessed whether the sedative eﬀect of mirtazapine
confounds our results. We added the participants’ self-assessment of
tiredness (right before fMRI, i.e. assessment 2) as a covariate in the 2nd
level model (one-sample t-test) of the drug group separately.
2.4. Static and dynamic functional connectivity
Functional connectivity between diﬀerent brain regions is usually
measured time-independently, over the whole scanning session, asses-
sing static synchrony between brain regions at rest or during speciﬁc
tasks. In correlation-based connectivity methods it is possible to use a
sliding time window to compute time-varying correlations, but higher
temporal resolution comes at the expense of reliability of the results
(Glerean et al., 2012; Sakoğlu et al., 2010). Recently it has been
demonstrated that using phase synchronization as a measure of
functional connectivity in fMRI data allows reliable computing of
time-varying synchronization with a maximal temporal resolution
(Glerean et al., 2012). Thus, seed-based phase synchronization (SBPS)
enables assessing instantaneous changes in synchronization between
brain regions evoked by complex, dynamic stimuli such as narratives or
movies (Glerean et al., 2012; Nummenmaa et al., 2014b).
We estimated average functional connectivity using Pearson's
correlation and instantaneous dynamic functional connectivity using
seed-based phase synchronization (SBPS (Glerean et al., 2012), code
available at: https://github.com/eglerean/funpsy). Because calculation
of all possible voxel-wise connections (~3.5*108 connections) would be
computationally prohibitive at native EPI data resolution, we spatially
down-sampled the data to 6 mm isotropic voxels prior to estimating the
time-variable functional connectivity. Voxels outside gray matter were
masked out, resulting in 5183 6 mm isotropic voxels considered as
functional nodes. This produced networks of ~13 million links. We ﬁrst
implemented further preprocessing steps following the recommenda-
tions of Power et al. (Power et al., 2014). Speciﬁcally, BOLD time series
Fig. 1. Experimental design for fMRI. A) Subjects listened to spoken emotional (pleasant and unpleasant) and neutral narratives. The narratives preceded a ﬁxation cross presented for 5 s
and a short title describing the general setting of the following story presented for 15 s. B) Valence and arousal time series (derived from a previous study (Nummenmaa et al., 2014b))
were used to assess neural responses to emotional content of the narratives.
Table 1
Mean valence and arousal ratings of the narratives (rescaled to range from 0 to 1).
UP=unpleasant narratives, PL=pleasant narratives, NE=neutral narratives. A one-way
analysis of variance (ANOVA) with Welch's F-test and Games-Howell's post hoc tests (due
to inhomogeneity of variance) was used to compare the means.
Mean UP
(SD)
Mean PL
(SD)
Mean NE
(SD)
F p
Valence 0.42
(0.11)a,b
0.78
(0.06)a,c
0.63
(0.05)b,c
F (2,16.57)
=42.20
0.001
Arousal 0.62 (0.10)b 0.48 (0.17) 0.38 (0.14) F(2,17.41)
=10.88
0.001
a UP vs PL p< 0.05.
b UP vs NE p<0.05.
c PL vs NE p<0.05.
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were band-pass ﬁltered at 0.01–0.08 Hz, head motion parameters were
regressed (Friston expansion, 24 regressors), as were signals at white
matter, ventricles, and cerebral spinal ﬂuid. Global signal was not
regressed. For each participant, a whole brain network was then
computed as the pair-wise Pearson's correlation between all nodes time
series. As a measure of group diﬀerences, for each link, we computed a
two-sample t-test on the Fisher-Z-transformed correlation values. For
the group statistic, mean frame-wise displacement was considered a
regressor of no interest (Yan et al., 2013). Statistical signiﬁcance and
multiple comparison correction were assessed with permutations using
a Network-Based Statistic (NBS) method (Zalesky et al., 2010). As there
are positive and negative t-values, NBS returned a signiﬁcance thresh-
old for the positive and negative tail. The most conservative of the two
thresholds was chosen (i.e. the maximum of the absolute value of the
two thresholds).
For the dynamic functional connectivity, we computed time series
of phase diﬀerence between pairs of voxels for each individual after
band-pass ﬁltering the BOLD signals at 0.04–0.07 Hz and Hilbert
transform (schematic in Fig. S1, for details see Glerean et al. (2012)).
To assess emotion-state speciﬁc eﬀects of mirtazapine, we computed a
two-sample t-test between the two groups for each link time series and
each time point so that we obtained a group level dynamic network of t-
value link time series. Also in this case, to control for head motion
confound, the instantaneous value of frame-wise displacement was used
as a regressor of no interest. Finally, to separate the eﬀects of valence
and arousal, the data were divided into segments (high and low valence
and high and low arousal). Valence and arousal were considered
separately due to a possible correlation between the two dimensions.
This produced four connectivity maps of link group diﬀerences
signiﬁcantly co-varying with valence and arousal. Control for multiple
comparisons was done as in (Nummenmaa et al., 2014b) by using
positive FDR (Storey and Tibshirani, 2003) with q<0.1.
For visualization, all connectivity maps were summarized by group-
ing nodes into predeﬁned anatomical regions (using AAL atlas). Only
the 20% of hubs with highest degree centrality, and betweenness
centrality at connection density of 10% (Rubinov and Sporns, 2010),
were included in the grouping. These maps thus show the connections
that were most prominently modulated by mirtazapine. Finally, voxel-
wise average node degrees were stored into a node degree or ‘hub’
maps, where voxel intensities reﬂect how many connections from each
voxel were statistically signiﬁcantly modulated (either positively or
negatively) by mirtazapine in the four diﬀerent conditions. Since node
degree maps are not statistical maps, the average 90th, 95th, and 99th
percentile were considered to represent the degree of importance of
each node in the four conditions (corresponding to mean node degree
values of 174, 224 and 331).
3. Results
3.1. Baseline characteristics
No signiﬁcant diﬀerences emerged between the groups in age,
comprehensive school grade point average, or gender (3 males in both
groups) (Table 2). In repeated measures ANOVA of the self-assessment
of tiredness there was a signiﬁcant main eﬀect of assessment time (F
(1,27)=9.54, p=0.005) and group*assessment time interaction (F
(1,27)=14.67, p=0.001), but the main eﬀect of group did not reach
statistical signiﬁcance (F(1,27)=3.54, p=0.071). The mirtazapine
group reported signiﬁcantly increased tiredness at assessment 2
(Table 2).
3.2. Regional eﬀects
There were no group diﬀerences in head motion (two-sample t-test
on mean frame-wise displacement: p=0.994; two sample t-test on
instantaneous frame-wise displacement not signiﬁcant at p<0.05,
FDR-corrected).
3.2.1. Eﬀect of valence and arousal in control group
Results for the control group are summarized in Fig. 2 (for peak
activations, see Table S1). Arousal was positively associated with
increased activation in limbic areas (including amygdala, hippocampus
and thalamus), striatum, primary and secondary motor areas, the
cortical midline structures (CMS; MPFC extending to supplementary
motor area (SMA), anterior cingulate (ACG), middle cingulate (DCG),
posterior cingulate (PCG) and precuneus), occipital cortex (primary
Table 2
Demographic characteristics and self-assessment of tiredness (Tiredness 1= self-assess-
ment 2 h before fMRI, Tiredness 2= self-assessment right before fMRI, likert scale 1–5).
Mean Mirtazapine
(SD)
Mean Control
(SD)
t value (p)
Age 23.5 (1.51) 23.8 (4.95) −0.22 (0.825)
Grade point
average
9.0 (0.40) 9.2 (0.54) −1.52 (0.140)
Tiredness 1 1.87 (0.74) 2.07 (0.88) −0.67 (0.508)
Tiredness 2 3.20 (1.08) 1.93 (0.92) 3.40 (0.002)
Fig. 2. Association of A) arousal and B) valence dimensions with BOLD signal in the
unmedicated control group only (p< 0.05, FDR-corrected at cluster level).
AMG=amygdala, Au1=primary auditory cortex, ACC=anterior cingulate cortex,
DLPFC=dorsolateral prefrontal cortex, INS=insula, MCC=middle cingulate cortex,
MPFC=medial prefrontal cortex, MTG=medial temporal gyrus, PCC=posterior cingu-
late cortex, PREC=precuneus, SMA=supplementary motor area, SMC=sensorimotor
cortex, THA=thalamus, V1=primary visual cortex, V2=secondary visual cortex.
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visual cortex and fusiform gyrus), temporoparietal regions (inferior
parietal cortex (IPC), middle temporal gyrus and posterior superior
temporal gyrus) and cerebellum. Valence was negatively associated
with activation of the dorsolateral prefrontal cortex (DLPFC), limbic
regions (including anterior insula, amygdala and hippocampus), DCG,
PCG, somatomotor cortex (left primary (SI) and secondary (SII)
somatosensory cortex and primary motor cortex), left IPC, occipital
cortex (including lingual gyrus and right fusiform gyrus) and cerebel-
lum. Activation in the auditory cortex (superior and transverse tempor-
al gyri) was positively associated with valence and negatively asso-
ciated with arousal.
3.2.2. Eﬀect of mirtazapine
Whole-brain BOLD-GLM analysis revealed that mirtazapine reduced
responses to arousing events of the stories in regions including bilateral
amygdala-hippocampal complex, thalamus, CMS, visual, somatosen-
sory (SI, SII), and motor cortices. Decreased responses to unpleasant
events were observed in the right anterior insula and lateral and
dorsolateral PFC. Overlapping eﬀect of mirtazapine on the responses
to high arousal and negative valence was seen in the ventromedial
prefrontal cortex (VMPFC) and the ventral anterior cingulate cortex
(vACC), visual, right somatosensory and motor cortices, temporopar-
ietal cortex, and cerebellum (Fig. 3).
Adding subjective tiredness as a covariate in the medication group t-
test of each contrast (valence and arousal) did not essentially change
the results. There was no signiﬁcant main eﬀect of tiredness on
responses of negative or arousing events of the stories in medication
or control group. Critically, mirtazapine did not signiﬁcantly decrease
responses to the stories when they were modeled as boxcar functions
without considering valence and arousal. In contrast, mirtazapine was
associated with increased responses to the stories in the bilateral
posterior hippocampus, posterior cingulate (PCG), and visual cortex.
3.3. Eﬀect on functional connectivity
3.3.1. Eﬀect of mirtazapine on average functional connectivity
Link-level connectivity diﬀerences across the whole experiment are
summarized in Fig. S2 (see list of abbreviations in Table S2). Controls
displayed on average higher connectivity values, with the most
important diﬀerences involving functional connections in subcortical
areas (thalamus, putamen, brainstem). The mirtazapine group showed
increased connectivity between middle cingulate (DCG) and premotor
areas (precentral gyrus, PreCG).
3.3.2. Eﬀect of mirtazapine on dynamic functional connectivity
Of the networks of links signiﬁcantly co-varying with the regressors,
high-valence and low-arousal networks had the highest number of links
for both control and mirtazapine groups (Table 3). Mirtazapine
increased functional connectivity associated with high valence in the
CMS (MPFC, ACG, DCG, PCG, and inferior parietal cortex (IPC)) and
limbic regions (thalamus and hippocampus) – see Fig. 4 top right panel.
This resulted primarily from increased connectivity between MPFC and
DCG, MPFC and middle temporal gyrus, and IPC and DCG (see Fig. 5,
bottom left panel). Mirtazapine decreased functional connectivity
associated with high valence in somatosensory and motor cortices,
DCG, and occipital regions (primary visual cortex, lingual gyrus, and
fusiform gyrus) (Fig. 4 top right panel). This resulted from decreased
connectivity between occipital and frontal areas, occipital and temporal
areas, and occipital areas and DCG (Fig. 5, top left panel). Mirtazapine
decreased functional connectivity associated with low valence mainly
in the thalamus, striatum, fronto-insular cortex, and anterior CMS
(MPFC, ACG, and DCG) and increased functional connectivity asso-
ciated with low valence in the posterior CMS (PCG and precuneus).
Mirtazapine increased functional connectivity associated with low
arousal in dorsofrontal areas (lateralized left), DMPFC, IPC, and
occipital cortex, including lingual gyrus, fusiform gyrus, and parahip-
pocampal gyrus (Fig. 4 bottom left panel, Fig. 5 bottom right panel).
Mirtazapine decreased functional connectivity associated with low
arousal in temporal areas, limbic regions (thalamus, hippocampus,
and amygdala), VMPFC, and vACG, and occipital regions, including the
primary visual cortex. Mirtazapine had virtually no eﬀect on functional
connectivity associated with high arousal.
Fig. 3. Brain regions with signiﬁcantly decreased activation in response to A) unpleasant
events and B) arousing events of the narratives in the mirtazapine group relative to the
control group. Statistical threshold at p<0.05, FDR-corrected at cluster level. AMG =
amygdala, INS=insula, LPFC=lateral prefrontal cortex, MCC=middle cingulate cortex,
MPFC=medial prefrontal cortex, PCC=posterior cingulate cortex, PREC=precuneus,
SMA=supplementary motor area, SMC=sensorimotor cortex, STRIA=striatum,
THA=thalamus, vACC=ventral anterior cingulate cortex, VMPFC=ventromedial pre-
frontal cortex, V1=primary visual cortex, V2=secondary visual cortex.
Table 3
Summary properties of the networks composed of links co-varying with low/high
valence/arousal for the two groups. Density is computed as signiﬁcant number of links
divided by total possible number of links in the network. Node degree is computed as
number of signiﬁcant links connected to a node.
Control group Mirtazapine group
Density (%) Node degree
(99th percentile)
Density (%) Node degree
(99th percentile)
Low valence 1.43 271 0.78 160
High valence 2.4 457 1.91 392
Low arousal 2.4 425 2.52 452
High arousal 0.79 182 0.84 184
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4. Discussion
A single dose of mirtazapine inﬂuenced neural responses and
dynamic functional connectivity related to both valence and arousal
dimensions of emotions while listening to spoken narratives lacking any
prosodic cues to their emotional content. Previous antidepressant
studies have used very simple emotional stimuli, most commonly
brieﬂy ﬂashed emotional faces, and have mainly found locally altered
activation, with attenuated limbic responses being the most consistent
ﬁnding (Harmer and Cowen, 2013; Ma, 2015). Our results indicate that
when using natural and complex emotional stimuli, and assessing not
only regional responses but also dynamic functional connectivity,
mirtazapine actually triggers large-scale changes spanning limbic,
sensorimotor, and midline brain structures.
4.1. Neural correlates of valence and arousal in the control group without
medication
In the control group, arousal was positively associated with activity
of limbic and subcortical emotion circuits, cortical midline structures,
temporo-parietal regions and visual and motor cortex. Valence was
negatively associated with activation of limbic regions, DLPFC and
sensorimotor cortex. This is in line with prior work showing that
arousal and valence have distinct but partially overlapping neural basis,
with arousal being associated with thalamus, insula, CMS and temporo-
parietal regions, and valence with core limbic regions including
amygdala, insula and thalamus (Nummenmaa et al., 2014b). Also,
previous studies using diﬀerent sensory modalities as stimuli suggest
that amygdala and thalamus may be important regions in tracking
arousal dimension of emotions and frontal region in tracking valence
dimension (Anderson et al., 2003; Colibazzi et al., 2010; Viinikainen
et al., 2010).
4.2. Eﬀect of mirtazapine on arousal processing
Mirtazapine decreased arousal-evoked responses of widespread
neural circuits involved in arousal processing, including core emotional
regions such as amygdala, thalamus, and striatum, the CMS, and
sensorimotor cortices. The attenuating eﬀect of mirtazapine on amyg-
dala responses to threat as well as decreased recognition of subtle
threatening stimuli have been observed in previous studies using simple
stimuli and interpreted to reﬂect the anxiolytic eﬀect of mirtazapine
(Arnone et al., 2009; Rawlings et al., 2010). However, using natural and
complex stimuli, closer to real-life emotional experiences, we observe a
markedly larger-scale eﬀect on arousal network.
It has been suggested that pathological anxiety may not be a
disorder of fear only, but rather a disorder of hypervigilance (Davis
and Whalen, 2001). Decrease in arousal-evoked responses of visual and
motor cortices suggests that mirtazapine may immediately modulate
vigilance, and consequently, actual sensory and motor responses to
arousing events possibly via bottom-up connections from limbic regions
to the neocortex. The CMS, such as DMPFC and DCG, have a role in
motor preparation in response to emotional cues (Narayanan and
Laubach, 2006; Oliveri et al., 2003; Vogt, 2005) and are implicated
Fig. 4. Node degree maps highlighting how many connections from each brain voxel were signiﬁcantly increased (hot colours) or decreased (cool colours) by mirtazapine during high and
low valence and arousal episodes.
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in avoidance behavior and fear processing (Oliveri et al., 2003; Vogt,
2005), receiving direct inputs from the amygdala (Vogt, 2005). Taken
together, the attenuating eﬀect of mirtazapine on the neural network
tracking arousal dimension could possibly reﬂect the anxiolytic eﬀect of
mirtazapine, which in depressed patients may result in decreased
sensory and behavioral responses to salient stimuli.
4.3. Eﬀect of mirtazapine on valence processing
Mirtazapine decreased responses to unpleasant events of the stories
in large-scale regions involved in valence processing, including right
insula and DLPFC, sensorimotor cortices, and the anterior CMS
(VMPFC, vACG). Insula is implicated in aﬀect perception and genera-
tion of aﬀective state (Phillips et al., 2003), interoceptive awareness
(Critchley et al., 2004), and subjective feelings (Phan et al., 2002).
DLPFC has a role in higher-order, voluntary regulation of emotions
(Phillips et al., 2008; Rive et al., 2013). Somatosensory cortex maps the
bodily sensations associated with emotional stimuli (Nummenmaa
et al., 2014a, 2008; Saarimäki et al., 2016), which constitute a core
component of subjective emotional feelings (Nummenmaa et al.,
2014a). The anterior CMS are also implicated in formation of subjective
feelings (Saarimäki et al., 2016), as they are connected with the
amygdala, primary sensory cortices, insula, midbrain, and brainstem,
thus receiving exteroceptive and interoceptive information (Northoﬀ
Fig. 5. Summary connectivity graphs showing the main network hubs whose interconnectivity mirtazapine decreased (top row) or increased (bottom row) during the high-valence and
low-arousal narrative episodes. The reported value is the number of signiﬁcant links between the two regions of interest (regions of interest based on the AAL atlas).
E. Komulainen et al. Psychiatry Research: Neuroimaging 263 (2017) 61–69
67
and Sibille, 2014; Ongur and Price, 2000). These regions have a key
role in self-referential processing, acting as a hub for tracking self-
relatedness of interoceptive and exteroceptive emotional signals
(Lemogne et al., 2012). Our results suggest that mirtazapine may
rapidly modulate neural circuits related not only to perception of
unpleasant events, but also those responsible for generating subjective
emotional feelings. Attenuation of the unpleasant subjective emotional
feelings might signiﬁcantly contribute to the therapeutic eﬀect of
mirtazapine. In line with this, MPFC and ACG are consistently
implicated in the pathogenesis of depression (Drevets et al., 2008;
Kaiser et al., 2015) and aﬀected by antidepressant medication (Ma,
2015). Further, ACG appears to be the most promising region to predict
treatment response of depressed patients across treatment modalities
(Pizzagalli, 2011), suggesting this region as a key target for eﬀective
treatment interventions.
4.4. Eﬀect of mirtazapine on large-scale functional connectivity associated
with valence and arousal
Mirtazapine inﬂuenced large-scale dynamic functional connectivity
related to valence and arousal dimensions of the stories. Mirtazapine
speciﬁcally increased functional connectivity associated with positive
valence and decreased functional connectivity associated with negative
valence in the CMS and core emotional circuitries (including thalamus,
hippocampus, insula, and striatum). Thus, mirtazapine was seen to
potentiate processing of positive information in line with the previous
ﬁndings of increased local responses to reward and simple positive cues
after a single dose (Rawlings et al., 2010; Vollm et al., 2006). Our
results suggest that mirtazapine may potentiate subjective experience
and self-referential processing of positive information via increased
cortical midline connectivity. However, mirtazapine decreased func-
tional connectivity of visual and somatomotor cortices as well as the
fusiform cortex associated with high valence. This may be related to the
general negative eﬀect of serotonergic antidepressants on aﬀective
experience sometimes reported (Price et al., 2009). Taken together, our
results from the connectivity analyses support mirtazapine not only
modulating local activity of single brain regions, but also modulating
functions of large-scale brain networks implicated in the pathogenesis
of depression (Drevets et al., 2008; Hamilton et al., 2012). These early
changes may be important for the therapeutic eﬀect of antidepressants.
This is supported by a recent study that found changes in resting-state
functional connectivity only 5 h after a single dose of escitalopram to
predict later treatment response in depressed patients (Cheng et al.,
2017).
4.5. Limitations
The sedative eﬀect of mirtazapine can be argued to drive the
observed changes in emotional responses. However, our control
analyses do not support this; adding the subjective assessment of
tiredness as a covariate in the medication group did not change the
overall pattern of emotion-dependent brain responses. Moreover, brain
responses to narratives per se (i.e. without modeling for aﬀective
features) did not diﬀer between the groups in auditory cortices or
cortical areas involved in semantic processing. This conﬁrms that the
sedative eﬀect of mirtazapine did not interfere with or alter listening to
and interpreting the narratives (Davis et al., 2007). The fact that
mirtazapine did not signiﬁcantly decrease neural responses to narra-
tives per se also conﬁrms that the group diﬀerences in responses to
emotional content of the narratives was not merely due to some
possible global eﬀects of mirtazapine on BOLD signal, e.g. via vasodi-
latations. However, it must be kept in mind that the study is limited by
its open-label design. Ideally, the eﬀects of mirtazapine should be
studied in a randomized, placebo-controlled, and double-blind design,
yet the sedative eﬀect of mirtazapine makes the blinding practically
impossible (see Section 2). We investigated healthy volunteers, and
thus, the generalizability of our ﬁndings to depressed patients requires
further studies. We used a single dose of mirtazapine. The adaptive
eﬀects of continuous medications can lead to diﬀerent results than
those seen here.
5. Conclusions
Mirtazapine inﬂuences regional responses and dynamic functional
connectivity of large-scale brain networks involved in encoding valence
and arousal dimensions of emotions during natural conditions. We
propose that these eﬀects reﬂect the antidepressant and anxiolytic
eﬀects of mirtazapine, respectively. Mirtazapine reduced emotion-
evoked activity in the core aﬀective (limbic) regions but also in sensory
and motor cortices as well as the CMS. The CMS integrate sensory and
emotional signals, and assess their self-relatedness, guiding appropriate
motor, sensory, and autonomic responses (Duncan and Barrett, 2007;
Murray et al., 2011; Northoﬀ and Sibille, 2014). Changes in dynamic
functional connectivity relative to the valence and arousal dimensions
were observed between limbic, sensory, and cortical midline networks.
These eﬀects were observed when subjects listened to spoken narratives
without prosodic emotional cues, meaning that higher-order cognitive
and linguistic processing was required to extract the emotional content.
Our results thus highlight that mirtazapine not only inﬂuences auto-
matic, ﬁght-or-ﬂight responses to biologically salient sensory signals,
but also modulates higher-level interaction between cognitive and
aﬀective processes during complex everyday events. The attenuation
of responses to negative events, modulation of activity and connectivity
in regions tracking self-relatedness of the events as well as increase of
functional connectivity associated with positive events may all be
relevant for the clinical eﬀectiveness of this antidepressant.
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